DT&CRO CO., Ltd. Logo

DT&CRO CO., Ltd.

A full-service CRO providing non-clinical and clinical studies for various industries.

383930 | KO

Overview

Corporate Details

ISIN(s):
KR7383930005
LEI:
Country:
South Korea
Address:
경기도 용인시 처인구 백령로20번길 28 나동 2, 3, 4층(유방동), 용인시

Description

DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides a comprehensive series of commissioned studies for the biopharmaceutical, chemical, functional food, and cosmetics sectors. The company's services span the entire development lifecycle, from non-clinical research, including GLP toxicity, pharmacokinetics (PK), and efficacy tests, to clinical trials, analysis, and regulatory consulting. Specialized offerings include a full-package service for FDA IND and NDA submissions, developed in partnership with Radyus Research. DT&CRO also provides an in-house SEND (Standard for Exchange of Nonclinical Data) program to streamline FDA registration and approval. Additionally, the company offers MoPS, a proprietary IT program that enables sponsors to manage projects and communicate with specialists in real-time.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-09-09 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB
2025-09-08 00:00
단일판매ㆍ공급계약체결(자율공시)
Korean HTML 9.0 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.1 MB
2025-08-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 26.7 KB
2025-08-08 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 88.3 KB
2025-06-16 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean HTML 41.8 KB
2025-06-11 00:00
임원ㆍ주요주주특정증권등거래계획철회보고서
Korean HTML 17.4 KB
2025-06-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.3 KB
2025-06-05 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 85.3 KB
2025-05-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2025-05-30 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 85.4 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.1 MB
2025-04-16 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean HTML 42.0 KB
2025-04-15 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean HTML 41.9 KB
2025-03-28 00:00
정기주주총회결과
Korean HTML 23.9 KB

Automate Your Workflow. Get a real-time feed of all DT&CRO CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DT&CRO CO., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DT&CRO CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.